Last update :
18/04/2024
References   References 872  
Type : Journal
Web link : https://doi.org/10.1177/106002809703101204

Research teams : Houston - M.D.Anderson Cancer Center
Authors : Zhang YP, Xu QA, Trissel LA, Gilbert DL, Martinez F.
Title : Compatibility and stability of paclitaxel combined with cisplatin and with carboplatin in infusion solutions.
Reference : Ann Pharmacotherapy ; 31: 1465-1470. 1997

Level of Evidence : 
Level of evidence B+
Physical stability : 
Visual examination Turbidimetry Particle counting 
Chemical stability : 
High Performance Liquid Chromatography - ultraviolet detector (HPLC-UV)
Stability defined as 90% of the initial concentration
Other methods : 
Comments : 
No comments for the degradation products

List of drugs
InjectionCarboplatin Anticancer drug
Compatible 2 mg/ml + InjectionPaclitaxel 0,3 & 1,2 mg/ml + NaCl 0,9% or Glucose 5%
InjectionCisplatin Anticancer drug
Compatible 0,2 mg/ml + InjectionPaclitaxel 0,3 & 1,2 mg/ml + Sodium chloride 0,9%
InjectionPaclitaxel Anticancer drug
Compatible 0,3 & 1,2 mg/ml + InjectionCarboplatin 2 mg/ml + NaCl 0,9% or Glucose 5%
Compatible 0,3 & 1,2 mg/ml + InjectionCisplatin 0,2 mg/ml + Sodium chloride 0,9%
Stability of mixtures
Polyolefine NaCl 0,9% or Glucose 5% 23°C Not specified
Injection Paclitaxel 0,3 & 1,2 mg/ml
Injection Carboplatin 2 mg/ml
24 Hour
Polyolefine NaCl 0,9% or Glucose 5% 32°C Not specified
Injection Paclitaxel 0,3 & 1,2 mg/ml
Injection Carboplatin 2 mg/ml
24 Hour
Polyolefine NaCl 0,9% or Glucose 5% 4°C Protect from light
Injection Paclitaxel 0,3 & 1,2 mg/ml
Injection Carboplatin 2 mg/ml
24 Hour

  Mentions Légales